EyePoint, Inc (EYPT NASDAQ) stock market data APIs
$0.4036
-0.02(-5%)
as of November 3, 2026
Try our APIs with
free plan!
EyePoint, Inc Financial Data Overview
Price chart is built with
Anychart
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for vascular endothelial growth factor mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as EyePoint Pharmaceuticals, Inc. and changed its name to EyePoint, Inc. in December 2025. EyePoint, Inc. was founded in 2000 and is headquartered in Watertown, Massachusetts.
Prev. Close
0.4036
Open
0.3788
High
0.4105
Low
0.3773
52 wk Range
0.34-19.11
Market Cap
31 424 K
Shares Outstanding
83 841 K
Revenue
2 788 K
Beta
1.904
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with EyePoint, Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EyePoint, Inc data using free add-ons & libraries
Get EyePoint, Inc Fundamental Data
EyePoint, Inc Fundamental data includes:
- Net Revenue: 2 788 K
- EBITDA: -314 376 000
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: -0.88
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EyePoint, Inc News
New
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Top Wealth Group Holdings Ltd. ...
Here's Why You Should Add EYPT Stock to Your Portfolio Now
EyePoint EYPT is a clinical-stage biotechnology company focused on developing treatments for serious retinal diseases that can lead to vision loss. The company's growth story largely depends on the s...
Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
Investing.com -- Mizuho Securities added software company Oracle Corp to its Top Picks list as a No. 1 pick, setting a $320 price target that is 25% above Bloomberg consensus on surging demand for its...
Street Calls of the Week
Monday - Lumentum Holdings What's the full story? Evercore initiates Lumentum Lumentum Holdings Inc (NASDAQ:LITE) at Outperform with an $1,100 target. The AI revolution has a supply-chain coronary: s...
Get EyePoint, Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.